Chronic fatigue syndrome: progress and possibilities
- PMID: 32248536
- DOI: 10.5694/mja2.50553
Chronic fatigue syndrome: progress and possibilities
Abstract
Chronic fatigue syndrome (CFS) is a prevalent condition affecting about one in 100 patients attending primary care. There is no diagnostic test, validated biomarker, clear pathophysiology or curative treatment. The core symptom of fatigue affects both physical and cognitive activities, and features a prolonged post-activity exacerbation triggered by tasks previously achieved without difficulty. Although several different diagnostic criteria are proposed, for clinical purposes only three elements are required: recognition of the typical fatigue; history and physical examination to exclude other medical or psychiatric conditions which may explain the symptoms; and a restricted set of laboratory investigations. Studies of the underlying pathophysiology clearly implicate a range of different acute infections as a trigger for onset in a significant minority of cases, but no other medical or psychological factor has been reproducibly implicated. There have been numerous small case-control studies seeking to identify the biological basis of the condition. These studies have largely resolved what the condition is not: ongoing infection, immunological disorder, endocrine disorder, primary sleep disorder, or simply attributable to a psychiatric condition. A growing body of evidence suggests CFS arises from functional (non-structural) changes in the brain, but of uncertain character and location. Further functional neuroimaging studies are needed. There is clear evidence for a genetic contribution to CFS from family and twin studies, suggesting that a large scale genome-wide association study is warranted. Despite the many unknowns in relation to CFS, there is significant room for improvement in provision of the diagnosis and supportive care. This may be facilitated via clinician education.
Keywords: Chronic fatigue syndrome; Diagnosis; Review article; Treatment outcome.
© 2020 AMPCo Pty Ltd.
Similar articles
-
[Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities].Nervenarzt. 1996 Sep;67(9):711-20. doi: 10.1007/s001150050045. Nervenarzt. 1996. PMID: 8992368 Review. German.
-
Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.Rev Environ Health. 2015;30(4):223-49. doi: 10.1515/reveh-2015-0026. Rev Environ Health. 2015. PMID: 26613325 Review.
-
Undiagnosed and comorbid disorders in patients with presumed chronic fatigue syndrome.J Psychosom Res. 2013 Nov;75(5):491-6. doi: 10.1016/j.jpsychores.2013.07.010. Epub 2013 Aug 20. J Psychosom Res. 2013. PMID: 24182640
-
Chronic fatigue syndrome. A practical guide to assessment and management.Gen Hosp Psychiatry. 1997 May;19(3):185-99. doi: 10.1016/s0163-8343(97)80315-5. Gen Hosp Psychiatry. 1997. PMID: 9218987 Review.
-
[Overview of psychiatric therapy for chronic fatigue syndrome].Nihon Rinsho. 2007 Jun;65(6):1082-6. Nihon Rinsho. 2007. PMID: 17561701 Review. Japanese.
Cited by
-
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).Front Immunol. 2022 Jan 3;12:628741. doi: 10.3389/fimmu.2021.628741. eCollection 2021. Front Immunol. 2022. PMID: 35046929 Free PMC article. Review.
-
Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials.Front Pharmacol. 2023 Oct 24;14:1266803. doi: 10.3389/fphar.2023.1266803. eCollection 2023. Front Pharmacol. 2023. PMID: 37942489 Free PMC article.
-
A New Approach of Fatigue Classification Based on Data of Tongue and Pulse With Machine Learning.Front Physiol. 2022 Feb 7;12:708742. doi: 10.3389/fphys.2021.708742. eCollection 2021. Front Physiol. 2022. PMID: 35197858 Free PMC article.
-
Understanding the Pivotal Role of the Vagus Nerve in Health from Pandemics.Bioengineering (Basel). 2022 Jul 29;9(8):352. doi: 10.3390/bioengineering9080352. Bioengineering (Basel). 2022. PMID: 36004877 Free PMC article.
-
Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.Nutrients. 2021 Jul 30;13(8):2658. doi: 10.3390/nu13082658. Nutrients. 2021. PMID: 34444817 Free PMC article. Clinical Trial.
References
-
- Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006; 367: 346-355.
-
- Rowe PC, Underhill RA, Friedman KJ, et al. Myalgic encephalomyelitis / chronic fatigue syndrome diagnosis and management in young people: a primer. Front Pediatr 2017; 5: 121.
-
- Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington, DC: National Academies Press (US), 2015.
-
- Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA 2015; 313: 1101-1102.
-
- Keech A, Sandler CX, Vollmer-Conna U, et al. Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome. J Psychosom Res 2015; 79: 537-549.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical